Guided Therapeutics, Inc. (GTHP) Stock
Guided Therapeutics, Inc. is a medical technology firm specializing in the creation of medical devices.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Guided Therapeutics, Inc.
Guided Therapeutics, Inc. is a medical technology firm specializing in the creation of medical devices. Its primary focus is on bringing to market LuViva, an innovative device designed for the non-invasive detection of cervical cancer. This technology excels at identifying both cancerous and precancerous conditions of the cervix in a painless, non-invasive manner, directly at the point of care. LuViva operates by scanning the cervix with light and subsequently analyzing both the reflected and fluorescent light emitted. Established in 1992 and headquartered in Norcross, Georgia, the company was formerly known as SpectRx, Inc. until its rebranding to Guided Therapeutics, Inc. in February 2008.
Guided Therapeutics, Inc. is headquartered in US.
Guided Therapeutics, Inc. (GTHP) stock trades at $0.24 with a market capitalization of $23.56M. The stock is valued at a price-to-earnings (P/E) ratio of -5.47, price-to-book of -4.19, price-to-sales of 30.71. Over the past 52 weeks the stock has ranged between $0.12 and $0.54, and currently trades 55.6% below its 52-week high.
On profitability, Guided Therapeutics, Inc. generates a return on equity (ROE) of 70.53% — well above the market average, a sign of a high-quality business, return on capital employed of 56.84%, an operating margin of -322.95%, a net profit margin of -512.65%.
Official website: www.guidedinc.com